Advanced Oncotherapy (AIM: AVO), the developer of a next generation proton therapy system for cancer treatment, announces audited results for the year ended 31 December 2018, another year of significant technological development of the Company’s first LIGHT system.
Advanced Oncotherapy (AIM: AVO), the developer of a next-generation proton therapy system for cancer treatment, announces positive results from its comparative study which further demonstrates the competitive advantages of the LIGHT system, the Company’s proprietary proton accelerator.
Advanced Oncotherapy (AIM: AVO), the developer of a next-generation proton therapy system for cancer treatment, announces the appointment of Moataz Karmalawy as Chief Commercial Officer and President of the US division with immediate effect. This appointment is a non-board appointment.
Advanced Oncotherapy (AIM: AVO), the developer of a next-generation proton therapy system for cancer treatment, is pleased to provide a comprehensive general technical update on the development of its LIGHT system following the recent announcement that the LIGHT system had achieved the key milestone of generating a beam with an energy level capable of treating superficial tumours.
Advanced Oncotherapy (AIM: AVO), the developer of a next generation proton therapy system for cancer treatment, announces its unaudited results for the six months ended 30 June 2018 and post-period events.
Advanced Oncotherapy (AIM: AVO), the developer of next generation proton therapy systems for cancer treatment, announces audited results for the year ended 31 December 2017, another year of significant technological development and installation of the Company’s first LIGHT system.
Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, provides the following technological update.
Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that discussions between Yantai Cipu, through its affiliated entity Liquid Harmony, and